AstraZeneca Shelves Symbicort Launch Until 2007 To Prolong Product Life

AstraZeneca is delaying the launch of its asthma therapy Symbicort (budesonide/formoterol) until mid-2007 as it works to develop a longer shelf life for the product, the company said